Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
P., Roskams T., Miyazaki H., Serreli S., Ambu R., & Desmet V
A double-blind RCT (n=150) in patients receiving sagopilone chemotherapy showed no reduction in CIPN incidence with LC, although a slight decrease in severity was observed in ovarian cancer patients (not in prostate cancer patients)
GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults
It is about using medically guided protocols backed by quality-focused sourcing and documented verification standards
US$ 25.73
US$ 23.57
US$ 29.84
US$ 21.00
US$ 23.48
US$ 29.59
US$ 20.43
